Dimerizer-regulated gene expression

Current Opinion in Biotechnology

Volumn 13, Issue 5, 2002, Pages 459-467

  Pollock, Roy ^a   Clackson, Tim ^a  

^a ARIAD PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; DEXAMETHASONE; METHOTREXATE; TACROLIMUS; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; DIMERIZATION; DNA DRUG COMPLEX; DRUG ACTIVITY; DRUG MECHANISM; DRUG PROTEIN BINDING; GENE EXPRESSION REGULATION; GENE THERAPY; HUMAN; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; REVIEW; TRANSCRIPTION REGULATION;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE;

EID: 0036810868     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(02)00373-7     Document Type: Review

References (40)

1. Clackson T. Regulated gene expression systems. Gene Ther. 7:2000;120-125.
2. Clackson T. Controlling mammalian gene expression with small molecules. Curr Opin Chem Biol. 1:1997;210-218.
3. Rossi F.M., Blau H.M. Recent advances in inducible gene expression systems. Curr Opin Biotechnol. 9:1998;451-456.
4. Ho S.N., Biggar S.R., Spencer D.M., Schreiber S.L., Crabtree G.R. Dimeric ligands define a role for transcriptional activation domains in reinitiation. Nature. 382:1996;822-826.
5. Amara J.F., Clackson T., Rivera V.M., Guo T., Keenan T., Natesan S., Pollock R., Yang W., Courage N.L., Holt D.A., et al. A versatile synthetic dimerizer for the regulation of protein-protein interactions. Proc Natl Acad Sci USA. 94:1997;10618-10623.
6. Pollock R., Rivera V.M. Regulation of gene expression with synthetic dimerizers. Methods Enzymol. 306:1999;263-281.
7. Abraham R.T. Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling. Curr Opin Immunol. 10:1998;330-336.
8. Rivera V.M., Clackson T., Natesan S., Pollock R., Amara J.F., Keenan T., Magari S.R., Phillips T., Courage N.L., Cerasoli F. Jr, et al. A humanized system for pharmacologic control of gene expression. Nat Med. 2:1996;1028-1032.
9. Abraham R.T., Wiederrecht G.J. Immunopharmacology of rapamycin. Annu Rev Immunol. 14:1996;483-510.
10. Serkova N., Jacobsen W., Niemann C.U., Litt L., Benet L.Z., Leibfritz D., Christians U. Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain. Br J Pharmacol. 133:2001;875-885.
11. Pomerantz J.L., Sharp P.A., Pabo C.O. Structure-based design of transcription factors. Science. 267:1995;93-96.
12. Magari S.R., Rivera V.M., Iuliucci J.D., Gilman M., Cerasoli F. Jr. Pharmacologic control of a humanized gene therapy system implanted into nude mice. J Clin Invest. 100:1997;2865-2872.
13. Pollock R., Issner R., Zoller K., Natesan S., Rivera V.M., Clackson T. Delivery of a stringent dimerizer-regulated gene expression system in a single retroviral vector. Proc Natl Acad Sci USA. 97:2000;13221-13226.
14. Natesan S., Molinari E., Rivera V.M., Rickles R.J., Gilman M. A general strategy to enhance the potency of chimeric transcriptional activators. Proc Natl Acad Sci USA. 96:1999;13898-13903.
15. Liberles S.D., Diver S.T., Austin D.J., Schreiber S.L. Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen. Proc Natl Acad Sci USA. 94:1997;7825-7830.
16. Ye X., Rivera V.M., Zoltick P., Cerasoli F. Jr, Schnell M.A., Gao G., Hughes J.V., Gilman M., Wilson J.M. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science. 283:1999;88-91.
17. Senner V., Sotoodeh A., Paulus W. Regulated gene expression in glioma cells: a comparison of three inducible systems. Neurochem Res. 26:2001;521-524. This article compares the early generation AP1510-based homodimerizer system with the Tet-off and ecdysone systems in transiently transfected rat C6 glioma cells. The dimerizer system was found to have the lowest basal levels of transcription and the highest induction ratios, but both the ecdysone and Tet-off systems supported higher levels of induced transcription. The AP1510-based system has now been superceded by the more effective rapamycin heterodimerizer system shown in Fig. 2.
18. Go W.Y., Ho S.N. Optimization and direct comparison of the dimerizer and reverse tet transcriptional control systems. J Gene Med. 4:2002;258-270. The authors compare a version of the rapamycin heterodimerizer system with an optimized Tet-on system in transient transfection assays in the Jurkat and NIH 3T3 cell lines. In an effort to eliminate all variables, transactivators were produced from identical expression vectors, contained the same activation domains, and were assayed on target promoters differing only in the transactivator DNA-binding sites. The Tet-on system gave the highest levels of induced transcription, but was 'leakier' than the dimerizer system. The authors conclude that the Tet-on system is suited to applications where high levels of target gene induction are required, whereas the dimerizer system is most useful where tight regulation is the priority. Note that the dimerizer system in this study used the Gal4 DBD in place of ZFHD1. Given that the Gal4-FKBP DBD fusion was found to non-specifically repress transcription when expressed at high levels, it is possible that this change reduced levels of target gene induction.
19. Rivera V.M., Ye X., Courage N.L., Sachar J., Cerasoli F. Jr, Wilson J.M., Gilman M. Long-term regulated expression of growth hormone in mice after intramuscular gene transfer. Proc Natl Acad Sci USA. 96:1999;8657-8662.
20. Pollock R., Giel M., Linher K., Clackson T. Regulation of endogenous gene expression with a small-molecule dimerizer. Nat Biotechnol. 20:2002;729-733. The authors replace ZFHD1 with an artificial zinc finger DBD targeting the human chromosomal VEGF gene promoter and demonstrate that the dimerizer system can be used to regulate the endogenous VEGF gene. Addition of a non-immunosuppressive C7-modified rapalog to cells transiently or stably transfected with the dimerizer-regulated zinc finger activator led to rapid, tight and dose-responsive induction of multiple VEGF splice variants to levels several fold higher than the natural hypoxic response. This is the first example of endogenous gene regulation via a designed zinc finger protein whose activity is under direct small-molecule control.
21. Molinari E., Gilman M., Natesan S. Proteasome-mediated degradation of transcriptional activators correlates with activation domain potency in vivo. EMBO J. 18:1999;6439-6447.
22. Beerli R.R., Barbas C.F. I.I.I. Engineering polydactyl zinc-finger transcription factors. Nat Biotechnol. 20:2002;135-141.
23. Vincent K.A., Shyu K.G., Luo Y., Magner M., Tio R.A., Jiang C., Goldberg M.A., Akita G.Y., Gregory R.J., Isner J.M. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1α/VP16 hybrid transcription factor. Circulation. 102:2000;2255-2261.
24. Biggar S.R., Crabtree G.R. Chemically regulated transcription factors reveal the persistence of repressor-resistant transcription after disrupting activator function. J Biol Chem. 275:2000;25381-25390.
25. Biggar S.R., Crabtree G.R. Cell signaling can direct either binary or graded transcriptional responses. EMBO J. 20:2001;3167-3176.
26. Clemons P.A., Gladstone B.G., Seth A., Chao E.D., Foley M.A., Schreiber S.L. Synthesis of calcineurin-resistant derivatives of FK506 and selection of compensatory receptors. Chem Biol. 9:2002;49-61. A study combining structure-based design, synthetic chemistry and genetics to generate a dimerizer system that responds to non-immunosuppressive analogs of FK506. Using the crystal structure of the FKBP-FK506-CnA-B complex as a guide, a single-chain calcineurin A/B fusion (mCAB) was created that can bind FKBP-FK506. Non-immunosuppressive FK506 analogs were designed by modifying the C40 position and destroying calcineurin binding affinity. A yeast three-hybrid selection system was then used to select mCABs that can bind to the analogs from a targeted randomized library. The resulting system could be used to obtain robust activation of a reported gene in transiently transfected mammalian (Jurkat) cells.
27. Licitra E.J., Liu J.O. A three-hybrid system for detecting small ligand-protein receptor interactions. Proc Natl Acad Sci USA. 93:1996;12817-12821.
28. Lin H., Abida W.M., Sauer R.T., Cornish V.W. Dexamethasone-methotrexate: an efficient chemical inducer of dimerization in vivo. J Am Chem Soc. 122:2000;4247-4248.
29. Althoff E.A., Cornish V.W. A bacterial small-molecule three-hybrid system. Angew Chem Int Ed Engl. 41:2002;2327-2330. Describes the development of a new heterodimerizer, methotrexate-SLF, for use in three-hybrid assays. Methotrexate binds to glucocorticoid receptor domains; SLF is a synthetic ligand for FKBP and is the monomeric subunit of AP1510. The dimerizer is used to set up a bacterial three-hybrid system in which inducible transcription is obtained in Escherichia coli by fusing FKBP to the λcI DBD and fusing DHFR to a portion of the α-subunit of RNA polymerase.
30. Auricchio A., Rivera V., Clackson T., O'Connor E., Maguire A., Tolentino M., Bennett J., Wilson J. Pharmacological regulation of protein expression from adeno-associated viral vectors in the eye. Mol Ther. 6:2002;238. Describes the use of the optimized rapamycin system to achieve inducible protein expression in the eyes of rats and primates. Two AAV vectors, one expressing the transcription factors and the other harboring an EPO target gene, were co-injected in a 1:1 ratio into the subretinal space of rat eyes and EPO levels in the anterior chamber were measured. Expression before induction was negligible, but administration of systemic rapamycin provoked dose-dependent and reversible inductions of EPO. Peak expression levels were higher than those obtained following injection of equivalent doses of vectors in which EPO was expressed from the constitutive CMV promoter. Similar results were also obtained in a single non-human primate.
31. Chong H., Ruchatz A., Clackson T., Rivera V.M., Vile R.G. A system for small-molecule control of conditionally replication-competent adenoviral vectors. Mol Ther. 5:2002;195-203. The rapamycin system is used to create an adenoviral vector whose replication can be induced pharmacologically. The E1 adenoviral genes that are critical for replication were placed downstream of the Z12 inducible promoter in an adenoviral vector. In cells co-infected with this vector and one expressing rapamycin-regulated transcription factors, viral titers could be increased by several orders of magnitude in response to a C7-modified rapalog; expression of a GM-CSF (granulocyte macrophage colony-stimulating factor) transgene on a third, replication-defective vector could also be induced. Similar results were obtained when the vectors were co-injected into tumor xenografts in mice.
32. Auricchio A., Gao G.P., Yu Q.C., Raper S., Rivera V.M., Clackson T., Wilson J.M. Constitutive and regulated expression of processed insulin following in vivo hepatic gene transfer. Gene Ther. 9:2002;963-971. The optimized rapamycin system is used to achieve inducible expression of insulin from mouse liver following adenoviral gene transfer. The system is again introduced using a two-vector approach. A series of modified proinsulin constructs are assessed in which removal of the C peptide (to liberate active insulin) can potentially be achieved by endogenously expressed proteases, with a furin-cleavable construct being the best. Tight, inducible expression of insulin is demonstrated, resulting in transient changes in blood glucose. Although the kinetics of transcriptional regulation may not be ideal for rapidly modulating blood glucose levels, this system might offer a viable alternative to administration of long-acting insulin for treatment of type I diabetes.
33. Luce M.J., Reiser J. Development of regulated lentiviral vectors. Mol Ther. 5:2002;S32.
34. Wang S., Petravicz J., Breakefield X. Drug-regulated gene expression in post-mitotic cells using amplicon vectors. Mol Ther. 3:2001;S400.
35. Rivera V.M., Wardwell S., Tang H., Wang X., Clackson T. Regulated delivery of secreted proteins following hydrodynamic delivery of DNA to mice. Mol Ther. 5:2002;S325.
36. Freiberg R.A., Ho S.N., Khavari P.A. Transcriptional control in keratinocytes and fibroblasts using synthetic ligands. J Clin Invest. 99:1997;2610-2615.
37. Diver S.T., Schreiber S.L. Single-step synthesis of cell-permeable protein dimerizers that activate signal transduction and gene expression. J Am Chem Soc. 119:1997;5106-5109.
38. Rivera V.M. Controlling gene expression using synthetic ligands. Methods. 14:1998;421-429.
39. Belshaw P.J., Ho S.N., Crabtree G.R., Schreiber S.L. Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. Proc Natl Acad Sci USA. 93:1996;4604-4607.
40. Clipstone N.A., Fiorentino D.F., Crabtree G.R. Molecular analysis of the interaction of calcineurin with drug-immunophilin complexes. J Biol Chem. 269:1994;26431-26437.